cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

© Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 9, No. 4


327 The Promises and Pitfalls of Reboxetine
Michelle E. Page
[Abstract] [Article] [Single Reprint]
343 BAY 38-7271:  A Novel Highly Selective and Highly Potent Cannabinoid Receptor Agonist for the Treatment of Traumatic Brain Injury
Frank Mauler, Ervin Horváth, Jean De Vry, Rainer Jäger, Thomas Schwarz, Steffen Sandmann, Corinna Weinz, Roland Heinig and Michael Böttcher
[Abstract] [Article] [Single Reprint]
359 Pharmacology of Acamprosate:  An Overview
Teodoro Zornoza, Maria J. Cano, Ana Polache and Luis Granero
[Abstract] [Article] [Single Reprint]
375 Neuropharmacological Profile of an Atypical Antipsychotic, NRA0562
Shiho Hirota, Naoya Kawashima, Shigeyuki Chaki and Shigeru Okuyama
[Abstract] [Article] [Single Reprint]


389   CNS Forum.  Advancements in Clinical Trials and Drug Development.  Philadelphia, PA.  July 29-30, 2003.
Alexander Scriabine
[Article] [Single Reprint]
396   AUTHOR INDEX for Volume 9
397   SUBJECT INDEX for Volume 9
400   Acknowledgement of Reviewers